Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-011373
Filing Date
2022-10-17
Accepted
2022-10-17 12:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 33659
2 filename2.txt TEXT-EXTRACT 10459
  Complete submission text file 0000000000-22-011373.txt   57499
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filed for) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations